BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRCA1
,
T cell receptor signaling pathway
,
Allergy to pollen
,
Lung
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
HMA
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Tumor biopsy at C1D1 or C2D8 of ovarian cancer patients treated with guadecitabine + pembrolizumab
Acute myelocytic leukemia ML-2 cells treated with SGI-110 alone or in combination with ASTX660
Explore Curated Studies Results
Literature
Most Relevant Literature
Enhanced Cd phytoextraction by rapeseed under future climate as a consequence of higher sensitivity …
Too Little, Too Late? Redefining the Legacy of HMAS Perth (I), an Australian Warship Sunk in Indones…
The Molecular Docking of MAX Fungal Effectors with Plant HMA Domain-Binding Proteins.
Fragment-Based Ligand Discovery Applied to the Mycolic Acid Methyltransferase Hma (MmaA4) from Mycob…
Multiple effects of the Na(+)/H (+) antiporter inhibitor HMA on cancer cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety of HMA-CD20 in Patients With HFrEF
STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS
Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to…
Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML
Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ